SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-361234
Filing Date
2021-12-17
Accepted
2021-12-17 16:46:01
Documents
2
Group Members
ALEX VIEUXEXPLORER PARENT LLCFOUNDER HOLDINGS LLCSTEVEN FLETCHER

Document Format Files

Seq Description Document Type Size
1 SC 13D d266838dsc13d.htm SC 13D 140375
2 EX-99.1 d266838dex991.htm EX-99.1 8326
  Complete submission text file 0001193125-21-361234.txt   150311
Mailing Address 260 MADISON AVENUE, SUITE 800 NEW YORK NY 10016
Business Address 260 MADISON AVENUE, SUITE 800 NEW YORK NY 10016 2122874092
BioPlus Acquisition Corp. (Subject) CIK: 0001856653 (see all company filings)

IRS No.: 981583272 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93123 | Film No.: 211502244
SIC: 6770 Blank Checks

Mailing Address 544 AIRPORT BOULEVARD SUITE 400 BURLINGAME CA 94010
Business Address 544 AIRPORT BOULEVARD SUITE 400 BURLINGAME CA 94010 (415) 518-6725
BioPlus Sponsor LLC (Filed by) CIK: 0001895859 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D